the publication�s purpose is to be a "force for good and a platform for much needed change and to generate critical debate".
.
. the software can help physicians administer emergency treatment more quickly and also predict the one's chances of developing dementia.
.
.
.: "arise: a phase 3 randomized trial of erenumab for episodic migraine."
.